Market Data 
Markets
Replies to post #191198 on Arrayit Corporation (ARYC)
(2) information in the marketplace since at least March 2, 2020, claiming that ARYC developed an approved COVID-19 blood test.
The doctor also pointed Action News Jax in the direction of the laboratory doing the testing --- the ‘Arrayit Corporation,’ based in California.
An Arrayit spokesperson tells Action News Jax their testing methods check blood samples for antibodies made in response to the presence of both allergies and the coronavirus.
“Blood will be taken; the sample will be then parsed into two different assays. One assay will be used to interrogate [Immunoglobulin E antibodies] for an allergic response. Arrayit will look at 48 different food allergens, and 72 different environmental allergens, and publish a report back to the doctor, that would be up to them to share with patient, that tells what the patient’s allergic responses are,” said spokesperson Paul K. Haje. “A second sample will be drawn from the card, and be used in another assay that will make a determination if the patient has an [Immunoglobulin G antibodies] response to one of 12 different unique markers for COVID-19.”
While the Arrayit test has not yet been reviewed by the FDA, the company is operating under FDA guidance.
According to its website, the FDA issued a policy on blood tests in March to allow “… developers to market their tests without prior FDA review if certain conditions outlined in the guidance document are met…” The FDA released a statement this week on its guidance surrounding blood tests, which can be found
On Friday, Haje sent Action News Jax the following statement:
“Thank you for the fair and unbiased reporting.
"As a result of your good work, Arrayit has put a review process in place to examine the messaging and educate the Clinics on how to properly communicate to their patient base. Arrayit has assigned an Executive with a degree in Journalism to conduct the reviews.
"This applies to all 1,400 clinics in the United States that offers the COVID-19 Antibody Screen in addition to the Allergy Test.
"Arrayit believes it is an important test to make available and wants the patients to be able to make an informed decision on the test should they decide to take it. Arrayit is using the news piece as a breeder document to help educate the Clinics offering the test.
